Grundlæggende statistik
Insider-profil | Adage Capital Management, L.P. |
Porteføljeværdi | $ 1.919.421.937 |
Nuværende stillinger | 58 |
Aktiviststillinger | 39 |
13D/G-arkivering
Dette er en liste over 13D- og 13G-arkiveringer lavet i det sidste år (hvis nogen). Klik på linkikonet for at se den fulde transaktionshistorik. Grønne rækker angiver nye positioner. Røde rækker angiver lukkede positioner.
Fil dato | Form | Sikkerhed | Forrige Aktier |
Nuværende Aktier |
Δandele % | % Ejerskab |
% ΔEjerskab | |
---|---|---|---|---|---|---|---|---|
2025-09-02 | PRAX / Praxis Precision Medicines, Inc. | 1.974.585 | 2.374.085 | 20,23 | 11,28 | 16,41 | ||
2025-08-12 | JANX / Janux Therapeutics, Inc. | 3.061.750 | 2.525.000 | -17,53 | 4,27 | -19,59 | ||
2025-08-12 | CDTX / Cidara Therapeutics, Inc. | 990.000 | 1.100.000 | 11,11 | 4,97 | -45,02 | ||
2025-08-12 | FULC / Fulcrum Therapeutics, Inc. | 3.000.000 | 4.589.000 | 52,97 | 8,50 | 52,88 | ||
2025-08-12 | IMUX / Immunic, Inc. | 1.398.600 | 10.479.337 | 649,27 | 9,99 | 544,52 | ||
2025-08-12 | ZEO / Zeo Energy Corp. | 760.000 | 760.000 | 0,00 | 3,22 | -45,88 | ||
2025-08-12 | INZY / Inozyme Pharma, Inc. | 0 | 0,00 | |||||
2025-08-12 | CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) | 6.954.000 | 8.403.000 | 20,84 | 6,29 | 20,50 | ||
2025-08-12 | WVE / Wave Life Sciences Ltd. | 12.516.500 | 15.016.500 | 19,97 | 9,65 | 18,40 | ||
2025-08-12 | SLNO / Soleno Therapeutics, Inc. | 4.392.696 | 3.575.964 | -18,59 | 7,10 | -25,89 | ||
2025-08-12 | CABA / Cabaletta Bio, Inc. | 3.634.475 | 9.002.580 | 147,70 | 9,99 | 34,45 | ||
2025-08-12 | ENSC / Ensysce Biosciences, Inc. | 74.711 | 74.711 | 0,00 | 3,15 | -40,79 | ||
2025-08-12 | PRQR / ProQR Therapeutics N.V. | 8.102.098 | 6.601.938 | -18,52 | 6,27 | -18,57 | ||
2025-08-12 | DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) | 14.614.449 | 9,99 | |||||
2025-08-12 | EYPT / EyePoint Pharmaceuticals, Inc. | 5.750.000 | 6.800.000 | 18,26 | 9,88 | 17,34 | ||
2025-08-12 | TCRX / TScan Therapeutics, Inc. | 1.350.000 | 2,52 | |||||
2025-08-12 | AMLX / Amylyx Pharmaceuticals, Inc. | 5.697.605 | 8.800.000 | 54,45 | 9,87 | 53,50 | ||
2025-08-12 | ALGS / Aligos Therapeutics, Inc. | 325.000 | 210.000 | -35,38 | 3,90 | -58,42 | ||
2025-08-12 | SDRL / Seadrill Limited | 4.200.535 | 3.138.286 | -25,29 | 5,04 | -25,44 | ||
2025-08-12 | ADGM / Adagio Medical Holdings, Inc. | 821.261 | 5,34 | |||||
2025-08-12 | TNGX / Tango Therapeutics, Inc. | 5.905.349 | 5,45 | |||||
2025-06-20 | / (38000Q201) | 50.912 | 0,37 | |||||
2025-05-12 | SLDB / Solid Biosciences Inc. | 1.754.159 | 6.729.484 | 283,63 | 8,68 | 90,77 | ||
2025-05-12 | TRAW / Traws Pharma, Inc. | 330.000 | 6,50 | |||||
2025-05-12 | ACRS / Aclaris Therapeutics, Inc. | 9.627.304 | 8.201.344 | -14,81 | 7,60 | -15,56 | ||
2025-05-12 | AEVA / Aeva Technologies, Inc. | 1.401.454 | 2,56 | |||||
2025-05-12 | URGN / UroGen Pharma Ltd. | 2.928.086 | 1.277.000 | -56,39 | 2,77 | -60,09 | ||
2025-05-12 | MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) | 8.503.780 | 1,07 | |||||
2025-05-12 | TARA / Protara Therapeutics, Inc. | 2.250.000 | 0 | -100,00 | 0,00 | -100,00 | ||
2025-05-12 | LXEO / Lexeo Therapeutics, Inc. | 2.209.615 | 237.953 | -89,23 | 0,70 | -89,52 | ||
2025-05-12 | ABEO / Abeona Therapeutics Inc. | 4.210.429 | 4.411.572 | 4,78 | 8,78 | -12,11 | ||
2025-02-12 | STR / Sitio Royalties Corp. | 6.263.396 | 7,90 | |||||
2025-02-12 | ZVRA / Zevra Therapeutics, Inc. | 3.650.000 | 6,84 | |||||
2025-02-12 | KPTI / Karyopharm Therapeutics Inc. | 6.551.055 | 5,18 | |||||
2025-02-12 | ETHM / Dynamix Corporation | 1.350.000 | 8,13 | |||||
2025-02-12 | MNPR / Monopar Therapeutics Inc. | 599.195 | 9,86 | |||||
2025-02-12 | ENGN / enGene Holdings Inc. | 2.329.768 | 1.528.768 | -34,38 | 3,00 | -43,07 | ||
2024-11-12 | KALV / KalVista Pharmaceuticals, Inc. | 1.419.792 | 3,29 | |||||
2024-11-12 | STRO / Sutro Biopharma, Inc. | 2.250.132 | 2,75 | |||||
2024-11-12 | NKTX / Nkarta, Inc. | 3.600.000 | 5,10 | |||||
2024-11-12 | AMAL / Amalgamated Financial Corp. | 716.262 | 2,34 | |||||
2024-11-12 | MGTX / MeiraGTx Holdings plc | 5.229.099 | 6,77 | |||||
2024-11-12 | VSTM / Verastem, Inc. | 0 | 0,00 | |||||
2024-11-12 | ANNX / Annexon, Inc. | 3.485.931 | 3,28 | |||||
2024-11-12 | AURA / Aura Biosciences, Inc. | 4.881.125 | 9,84 | |||||
2024-11-12 | VINP / Vinci Compass Investments Ltd. | 0 | 0,00 | |||||
2024-11-12 | RZLT / Rezolute, Inc. | 2.842.163 | 4,91 | |||||
2024-11-12 | PWP / Perella Weinberg Partners | 1.037.615 | 1,90 | |||||
2024-11-12 | GHLD / Guild Holdings Company | 597.110 | 2,84 | |||||
2024-11-12 | SVRA / Savara Inc. | 6.753.701 | 4,10 | |||||
2024-11-12 | CRBP / Corbus Pharmaceuticals Holdings, Inc. | 528.937 | 4,39 | |||||
2024-11-12 | HOWL / Werewolf Therapeutics, Inc. | 2.000.594 | 4,58 | |||||
2024-11-12 | MTEM / Molecular Templates, Inc. | 0 | 0,00 | |||||
2024-11-12 | VERU / Veru Inc. | 7.861.111 | 5,37 | |||||
2024-11-12 | HRTX / Heron Therapeutics, Inc. | 8.850.000 | 5,84 | |||||
2024-11-12 | TENX / Tenax Therapeutics, Inc. | 369.097 | 9,99 | |||||
2024-11-04 | GLYC / GlycoMimetics, Inc. | 5.091.231 | 7,90 | |||||
2024-10-22 | ORKA / Oruka Therapeutics, Inc. | 175.000 | 0,50 |